The International Osteoporosis Foundation (IOF) is pleased to announce the appointment of Professor René Rizzoli as the next Editor-in-Chief for the European Office of Osteoporosis International and Archives of Osteoporosis, effective 1 September 2026. 

Professor René Rizzoli, MD, is an internist and endocrinologist with subspecialty expertise in metabolic bone diseases, osteoporosis, and disorders of mineral metabolism. He is Emeritus Professor of Medicine at the University Hospitals of Geneva, former Head of the Service of Bone Diseases and former Chair of the Department of Rehabilitation and Geriatrics. Professor Rizzoli previously served as Chair of the IOF Committee of Scientific Advisors and currently chairs the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). 

As former Editor-in-Chief of Calcified Tissue International, former editor of BONE and as Associate Editor of Osteoporosis International, Professor Rizzoli brings extensive editorial experience to the role, along with a longstanding commitment to scientific excellence and a strong vision for the journal’s future. 

As Editor-in-Chief of the European office of Osteoporosis International, Professor Rizzoli will work closely with the US Editor-in-Chief (appointed by the Bone Health and Osteoporosis Foundation), the Editorial Board, authors, reviewers, and IOF. 

Commenting on his appointment, Professor Rizzoli said: “I am honoured by the opportunity to serve as Editor-in-Chief of Osteoporosis International. I look forward to building on the journal’s strong reputation as one of the world's foremost publications in osteoporosis and metabolic bone diseases. Through the publication of rigorous, impactful, peer-reviewed research, the journal will continue to advance scientific knowledge, inform clinical practice, and improve musculoskeletal health worldwide.”

With appreciation to Professor John A. Kanis

Professor Rizzoli succeeds Professor John A. Kanis, who has served as Editor-in-Chief for the European Office since 2008. Over the past 18 years, Professor Kanis has played a pivotal role in the journal’s growth and evolution. Under his leadership, Osteoporosis International strengthened its international standing, attracted outstanding research from around the world, and further established its reputation as one of the leading journals in osteoporosis and metabolic bone disease. His vision, dedication, and commitment to scientific excellence have left a lasting legacy.

IOF President Professor Nicholas Harvey said: “On behalf of IOF’s Board of Governance and members, I extend our sincere gratitude to Professor Kanis for his exceptional leadership and many years of dedicated service. Through his vision and commitment, he has helped shape Osteoporosis International into one of the world's leading journals in the field and has laid a strong foundation for its continued success.”

“We are delighted to welcome Professor René Rizzoli as Editor-in-Chief for the European Office. Professor Rizzoli is an internationally respected clinician, researcher and editor whose extensive publishing experience and scientific leadership make him exceptionally well placed to lead the journal into its next chapter. We look forward to working with him as Osteoporosis International continues to advance excellence in osteoporosis and metabolic bone disease research worldwide.”

###

About Osteoporosis International

An international multi-disciplinary journal which is a joint initiative between the International Osteoporosis Foundation and the National Osteoporosis Foundation of the USA, Osteoporosis International provides a forum for the communication and exchange of current ideas concerning the diagnosis, prevention, treatment and management of osteoporosis and other metabolic bone diseases. It publishes original papers - reporting progress and results in all areas of osteoporosis and its related fields; review articles - reflecting the present state of knowledge in special areas of summarizing limited themes in which discussion has led to clearly defined conclusions; educational articles - giving information on the progress of a topic of particular interest; case reports - of uncommon or interesting presentations of the condition. While focusing on clinical research, the Journal also accepts submissions on more basic aspects of research, where they are considered by the editors to be relevant to the human disease spectrum.
2025 Impact Factor: 5.4
5-year Impact Factor: 5.5
Ranked 40th of 198 journals in the category Endocrinology and Metabolism
https://link.springer.com/journal/198

About IOF 
The International Osteoporosis Foundation (IOF) is the world’s largest nongovernmental organization dedicated to the prevention, diagnosis, and treatment of osteoporosis and related musculoskeletal diseases. Its members — including committees of leading scientific researchers and 349 patient, medical, and research organizations across 152 countries — work together to make fracture prevention and healthy mobility a global healthcare priority.
www.osteoporosis.foundation   @iofbonehealth